Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

por Manson, Guillaume, Brice, Pauline, Herbaux, Charles, Bouabdallah, Kamal, Antier, Chloé, Poizeau, Florence, Dercle, Laurent, Houot, Roch
Publicado 2020

P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PH...

por Iyer, Swaminathan, Jagadeesh, Deepa, Domingo Domènech, Eva, Benedetti, Fabio, Rodriguez Izquierdo, Antonia, Bouabdallah, Kamal, Vitolo, Umberto, Illidge, Tim, Liu, Jingmin, Knowles, Scott, Horwitz, Steven
Publicado 2023

Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma

por Bouard, Louise, Tessoulin, Benoit, Thieblemont, Catherine, Bouabdallah, Kamal, Gastinne, Thomas, Oberic, Lucie, Carras, Sylvain, Delette, Caroline, Casasnovas, Olivier, Dartigeas, Caroline, Cacheux, Victoria, Masse, Sibylle, Hermine, Olivier, Le Gouill, Steven
Publicado 2022

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.

por Le Gouill, Steven, Morschhauser, Franck, Chiron, David, Bouabdallah, Kamal, Cartron, Guillaume, Olivier Casasnovas, Rene, Milin, Caroline, Herbaux, Charles, Tchernonog, Emmanuelle, Rossi, Cedric, Rule, Simon, Gastinne, Thomas, Callanan, Mary, Tessoulin, Benoit
Publicado 2023

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study

por Morschhauser, Franck, Bouabdallah, Kamal, Stilgenbauer, Stephan, Thieblemont, Catherine, de Guibert, Sophie, Zettl, Florian, Gelbert, Lawrence M., Turner, P. Kellie, Kambhampati, Siva Rama Prasad, Li, Li, Li, Lily Q., Buchanan, Sean, Barriga, Susana, Bear, Melissa M., Wilhelm, Martin, Hess, Georg
Publicado 2020

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY

por Trotman, Judith, Luigi Zinzani, Pier, Mayer, Jiri, Flowers, Chris, Bijou, Fontanet, Carla Oliveira, Ana, Bouabdallah, Kamal, Johnson, Rod, Martin Garcia-Sancho, Alejandro, Provencio Pulla, Mariano, Trneny, Marek, Tilly, Hervé, Jurczak, Wojciech, Ivanova, Elena, Kim, Pil, Greenbaum, Adam, Huang, Sha, Delarue, Richard, Auer, Rebecca
Publicado 2023

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.

por Sarkozy, Clementine, Thieblemont, Catherine, Oberic, Lucie, Moreau, Anne, Bouabdallah, Kamal, Laurent Damaj, Gandhi, Gastinne, Thomas, Ribrag, Vincent, Olivier Casasnovas, Rene, Haioun, Corinne, Houot, Roch, Jardin, Fabrice, Neste, Eric Van Den, Cheminant, Morgane, Morschhauser, Franck, Callanan, Mary, Ghesquieres, Herve, Gressin, Remy, Hermine, Olivier, Le Gouill, Steven
Publicado 2023

P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY.

por Vic, Samuel, Thibert, Jean-Baptiste, Bachy, Emmanuel, Cartron, Guillaume, Gastinne, Thomas, Yakoub-Agha, Ibrahim, Le Bras, Fabien, Bouabdallah, Kamal, Despas, Fabien, Olivier Bay, Jacques, Rubio, Marie-Thérèse, Mohty, Mohamad, Olivier Casasnovas, Rene, Choquet, Sylvain, Castilla-Llorente, Cristina, Guidez, Stephanie, Loschi, Michael, Guffroy, Blandine, Carras, Sylvain, Rochelle, Laurianne Drieu La, Houot, Roch
Publicado 2023

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

por Jullien, Maxime, Tessoulin, Benoit, Ghesquières, Hervé, Oberic, Lucie, Morschhauser, Franck, Tilly, Hervé, Ribrag, Vincent, Lamy, Thierry, Thieblemont, Catherine, Villemagne, Bruno, Gressin, Rémy, Bouabdallah, Kamal, Haioun, Corinne, Damaj, Gandhi, Fornecker, Luc-Matthieu, Schiano De Colella, Jean-Marc, Feugier, Pierre, Hermine, Olivier, Cartron, Guillaume, Bonnet, Christophe, André, Marc, Bailly, Clément, Casasnovas, René-Olivier, Le Gouill, Steven
Publicado 2021

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

por Armand, Philippe, Rodig, Scott, Melnichenko, Vladimir, Thieblemont, Catherine, Bouabdallah, Kamal, Tumyan, Gayane, Özcan, Muhit, Portino, Sergio, Fogliatto, Laura, Caballero, Maria D., Walewski, Jan, Gulbas, Zafer, Ribrag, Vincent, Christian, Beth, Perini, Guilherme Fleury, Salles, Gilles, Svoboda, Jakub, Zain, Jasmine, Patel, Sanjay, Chen, Pei-Hsuan, Ligon, Azra H., Ouyang, Jing, Neuberg, Donna, Redd, Robert, Chatterjee, Arkendu, Balakumaran, Arun, Orlowski, Robert, Shipp, Margaret, Zinzani, Pier Luigi
Publicado 2019

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

por Morschhauser, Franck, Nastoupil, Loretta, Feugier, Pierre, Schiano de Colella, Jean-Marc, Tilly, Hervé, Palomba, Maria Lia, Bachy, Emmanuel, Fruchart, Christophe, Libby, Edward N., Casasnovas, Rene-Olivier, Flinn, Ian W., Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L., Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Le Gouill, Steven, Daguindau, Nicolas, Guidez, Stéphanie, Pica, Gian Matteo, García-Sancho, Alejandro Martín, López-Guillermo, Armondo, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Kalung, Wu, Sehn, Laurie H., Izutsu, Koji, Cartron, Guillaume, Gkasiamis, Argyrios, Crowe, Russell, Xerri, Luc, Fowler, Nathan H., Salles, Gilles
Publicado 2022